Full service lateral flow development company specializing in the design and manufacture of ultra-sensitive quantitative diagnostic assays
Every assay is unique. These are the steps we take with you to commercialize your next assay.
ISO 13485:2016 registered Quality Management System
Decades of combined experience from experts in the field
High-quality gold reagents offer robust, reproducible assays with highly sensitive visual detection
Full contract lateral flow assay development from feasibility to manufacturing
On-site bulk manufacturing of colloidal gold reporter probes
With our high-throughput lateral flow assay manufacturing capabilities, nanoComposix is the efficient solution to help bring your company’s completed assays to market.
We’ve combined our nanomaterials expertise and comprehensive knowledge of medical devices to develop innovative manufacturing solutions that are tailored to meet your unique needs. Our automated reel-to-reel reagent deposition and lamination platforms generate high-sensitivity devices with proven reproducibility under our ISO 13485:2016 certified Quality Management System.
Our resident biochemistry experts and on-site commercial-scale automated manufacturing provide unparalleled flexibility from start to finish, helping medical device companies bring new products to market with ease.
The existing standard method of detection for this food safety assay requires multiple days and a skilled scientist to perform the test. Using ultra-sensitive nanoparticle technologies, nanoComposix is developing a rapid lateral flow assay that can identify dangerous bacterial pathogens in less than 10 minutes.
Using the gold nanoshells, the non-profit group was able to achieve the desired sensitivity for their assay. The assay was transferred to nanoComposix for transfer to scale-up manufacturing under our Quality Management System. The assays were manufactured (50K strips) for testing in third world countries and are currently being evaluated in the field.
This customer turned to nanoComposix after three years of assay development where assay sensitivity could not be achieved by an internal team or with two separate contract assay development manufactures. The first company spent 6-months optimizing the assay and could not reach the required limit of detection. The second development company used proprietary nanobeads which achieved sensitivity but dried conjugate was unstable after 6 weeks. After a one-month effort, nanoComposix achieved the clinically relevant sensitivity using gold nanoshells.
We’re here to help!
Our knowledgeable technical staff is available to help with your specific product, project, and technical questions. We look forward to learning more about what you’re doing and how we can help you succeed.
Fields marked with * are required.